•
Sep 30, 2023

Seres Therapeutics Q3 2023 Earnings Report

Total Revenue
$310K
Previous year: $3.44M
-91.0%
EPS
-$0.37
Previous year: -$0.49
-24.5%
Gross Profit
-$209K
Previous year: -$39.7M
-99.5%
Cash and Equivalents
$170M
Previous year: $205M
-17.3%
Free Cash Flow
-$61.1M
Previous year: -$60.8M
+0.4%
Total Assets
$368M
Previous year: $312M
+17.9%

Seres Therapeutics

Seres Therapeutics